{
  "id": 15753347,
  "title": "ADHD medications offer promise in managing menopausal brain fog",
  "url": "https://urgent.news/2026/10/20/adhd-medications-offer-promise-in-managing-menopausal-brain-fog",
  "topic": "science",
  "section": "Science",
  "published": "2026-10-20T13:40:13.000Z",
  "source": {
    "name": "Medical Xpress",
    "slug": "medical-xpress",
    "url": "https://medicalxpress.com/news/2026-10-adhd-medications-menopausal-brain-fog.html"
  },
  "original_language": "en",
  "account": null,
  "summary": "An estimated 44% to 60% of perimenopausal women report cognitive changes like forgetfulness and trouble concentrating—also known as brain fog. Despite the effect of these symptoms on quality of life and productivity, there is currently no FDA-approved pharmacological intervention.",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}